Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
MedMira expands European product line with offering in the European Union
February 14th, 2007
MedMira Inc., (MIR) a provider of rapid diagnostic products, announced that it is expanding its rapid HIV test product line in the European Union. The company has recently been approved, under its CE Mark, to offer the MiraCare rapid HIV antibody test (MiraCare HIV) in two formats, laboratory format and point-of-care format. Both formats of MiraCare HIV have also been approved for an extended shelf life of 18 months. MedMira's European distribution network has already begun to take advantage of the new product format and features. Voden Medical Instruments, MedMira's exclusive distributor in Italy, increased their latest order of MiraCare HIV by 100%...
Source: Vaccine Weekly (2007-02-14)
|
